Spruce Biosciences, Inc. Common Stock (SPRB)

• Market cap: $61.6M
• 1 day: -6.53%
• 5 days: -9.26%
• 1 month: -24.09%
• 3 months: -32.77%
• 6 months: 448.78%
• Year to date: -40.71%
• 1 year: 99.63%
• 5 years: -96.08%
• 10 years: -95.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20